Trials / Completed
CompletedNCT01113593
A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease
A Randomized, Multiple-Dose, Crossover Study Characterizing the Pharmacodynamic Profiles of Formoterol Fumarate Inhalation Solution and Formoterol Dry Powder Inhaler in Subjects With Stable Chronic Obstructive Pulmonary Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Dey · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to characterize the pharmacodynamic profile of Formoterol Fumarate and Foradil Aerolizer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Formoterol Fumarate | Inhalation solution |
| DRUG | Formoterol Fumarate | Inhalation solution |
| DRUG | Formoterol Fumarate | Inhalation solution |
| DRUG | Foradil Aerolizer | Dry powder inhaler |
| DRUG | Foradil Aerolizer | Dry powder inhaler |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2010-05-01
- First posted
- 2010-04-30
- Last updated
- 2013-05-27
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01113593. Inclusion in this directory is not an endorsement.